title: Hyperbaric oxygen effect on MMP-9 after a vascular insult.
abstract: Matrix metalloproteinease-9 (MMP-9) is involved in a host of processes. Many of its processes are physiologically beneficial as well as detrimental. The over-expression of this enzyme has been implicated as a contributory factor to some of the sequalae associated with cerebral ischemia, cell death, non-healing wounds, traumatic brain injury, aneurysms, and plaque instability in atherosclerosis. Several studies have examined the effect of hyperbaric oxygen (HBO) on MMP-9 expression. Because this proteinase is involved in both chronic and acute pathology, we wanted to investigate an acute expression model and see if, and how quickly, its expression would respond to HBO therapy. Our patient was scheduled to have elective surgery with an overnight stay followed by a series of HBO exposures. The patient served as her own control. An MMP-9 and urine pH was obtained prior to surgery to establish a baseline. On days 1, 3, and 4 post-op, samples were obtained before and after hyperbaric exposure. The patient was exposed to 100% O2 at 2.5 ATA for 60 min during each treatment for 5 days. The patient's MMP-9 values were dramatically elevated after surgery as compared to the baseline readings. The percentage increase from baseline was 400%. Our patient showed a significant reduction in MMP-9 expression after each hyperbaric exposure with the greatest decrease seen on post-op day 1 and subsequent exposures showing slightly less expression. Reduction in MMP-9 expression ranged from 46% on day 1 to 30% on post-op day 4. This case study suggests that if done relatively soon after a vascular or tissue insult, HBO can reduce MMP-9 expression. Chronic vascular pathologies, such as atherosclerotic plaque and aneurysms where over-expression of MMP-9 may result in acute coronary syndrome (ACS) or cerebral vascular accidents (CVAs), may be mitigated by a series of HBO treatments that reduce MMP-9 expression. Causality and/or contributory effects of MMP-9 expression in both pathologic and physiologic processes needs to be further elucidated. The understanding of how HBO therapy modulates these may provide an additional insight into mechanisms and future potential therapies for pathologic conditions such as those described above.
authors.affiliation: Healing Chambers of America's, 995 Gateway Center Way, San Diego, CA, USA. FCumminsJr_DO@msn.com
authors.forename: Francis J
authors.initials: FJ
authors.lastname: Cummins
authors.forename: Laurie J
authors.initials: LJ
authors.lastname: Gentene
mesh_terms: D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D015971:Gene Expression Regulation, Enzymologic; D006801:Humans; D006863:Hydrogen-Ion Concentration; D006931:Hyperbaric Oxygenation; D020780:Matrix Metalloproteinase 9 / Q000097:blood*; D008875:Middle Aged; D019651:Plastic Surgery Procedures / Q000009:adverse effects*; D013997:Time Factors; D014556:Urine / Q000737:chemistry; D057772:Vascular System Injuries / Q000201:enzymology / Q000209:etiology / Q000628:therapy* / Q000652:urine
chemical_list: D020780:Matrix Metalloproteinase 9
references.citation: Brain Res. 2006 Mar 3;1076(1):231-7
references.pmid: 16480689
references.citation: Gerontology. 2007;53(2):63-73
references.pmid: 17047333
references.citation: Ann Anat. 2005 Nov;187(5-6):473-85
references.pmid: 16320827
references.citation: Knee Surg Sports Traumatol Arthrosc. 2007 Apr;15(4):443-52
references.pmid: 17187281
references.citation: J Neurosci. 2000 Sep 15;20(18):7037-42
references.pmid: 10995849
references.citation: Cardiol Rev. 2009 Nov-Dec;17(6):280-2
references.pmid: 19829177
references.citation: Wound Repair Regen. 2009 Mar-Apr;17(2):179-84
references.pmid: 19320885
references.citation: Am J Cardiol. 2004 Jun 15;93(12):1533-5
references.pmid: 15194029
references.citation: Arterioscler Thromb Vasc Biol. 2007 Jan;27(1):15-26
references.pmid: 17082488
references.citation: Arterioscler Thromb Vasc Biol. 2000 Jun;20(6):1637-43
references.pmid: 10845883
references.citation: Am J Physiol Cell Physiol. 2000 Feb;278(2):C292-302
references.pmid: 10666024
references.citation: Acta Neurochir Suppl. 2010;106:47-9
references.pmid: 19812919
references.citation: J Neuroinflammation. 2009 Nov 04;6:32
references.pmid: 19889224
references.citation: Neuropathol Appl Neurobiol. 2006 Feb;32(1):40-50
references.pmid: 16409552
references.citation: J Neurotrauma. 2009 Nov;26(11):1935-41
references.pmid: 19469687
references.citation: Cancer Lett. 2009 Oct 18;284(1):80-5
references.pmid: 19427114
references.citation: Undersea Hyperb Med. 2010 May-Jun;37(3):141-50
references.pmid: 20568543
references.citation: Stroke. 2009 Aug;40(8):2836-42
references.pmid: 19556529
references.citation: Crit Rev Oral Biol Med. 1993;4(2):197-250
references.pmid: 8435466
references.citation: Neurol Res. 2009 Mar;31(2):114-21
references.pmid: 19298750
references.citation: Matrix Suppl. 1992;1:245-55
references.pmid: 1480034
references.citation: Mol Med. 2008 Mar-Apr;14(3-4):175-83
references.pmid: 18079998
references.citation: Atherosclerosis. 2007 Jul;193(1):28-35
references.pmid: 16973170
references.citation: Acta Neurochir Suppl. 2008;105:191-6
references.pmid: 19066108
references.citation: Stroke. 2002 Nov;33(11):2711-7
references.pmid: 12411666
references.citation: Glia. 2009 Jan 1;57(1):24-38
references.pmid: 18661553
references.citation: Arthritis Rheum. 2008 Mar;58(3):854-63
references.pmid: 18311803
references.citation: Eur J Vasc Endovasc Surg. 2005 Sep;30(3):259-62
references.pmid: 16009575
references.citation: J Am Coll Cardiol. 2010 Mar 23;55(12):1240-1249
references.pmid: 20298932
references.citation: Neurosurgery. 2009 Oct;65(4):702-8
references.pmid: 19834375
references.citation: J Orthop Res. 2011 Jan;29(1):14-9
references.pmid: 20661932
references.citation: Int Wound J. 2008 Oct;5(4):543-51
references.pmid: 18808434
references.citation: J Cereb Blood Flow Metab. 2000 Dec;20(12):1681-9
references.pmid: 11129784